Discovery and structural investigation of Varicella-Zoster virus gE-neutralizing antibodies isolated from a convalescent patient
Authors:
Open Access
- 30 June 2025
- journal article
- Published by Oxford University Press (OUP) in Protein & Cell
- Vol. 16 (12) , 1054-1059
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Discovery and characterization of potent pan-variant SARS-CoV-2 neutralizing antibodies from individuals with Omicron breakthrough infectionNature Communications, 2023
- A glycoprotein B-neutralizing antibody structure at 2.8 Å uncovers a critical domain for herpesvirus fusion initiationNature Communications, 2020
- Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B CellsCell, 2020
- Safety and Varicella Outcomes in In Utero–Exposed Newborns and Preterm Infants Treated With Varicella Zoster Immune Globulin (VARIZIG): A Subgroup Analysis of an Expanded-Access ProgramJournal of the Pediatric Infectious Diseases Society, 2019
- A highly conserved epitope-vaccine candidate against varicella-zoster virus induces neutralizing antibodies in miceVaccine, 2016
- Varicella zoster virus infectionNature Reviews Disease Primers, 2015
- Postherpetic NeuralgiaNew England Journal of Medicine, 2014
- Molecular mechanisms of varicella zoster virus pathogenesisNature Reviews Microbiology, 2014
- Induction of neutralizing antibody and T-cell responses to Varicella-zoster virus (VZV) using Ty-virus-like particles carrying fragments of glycoprotein E (gE)Vaccine, 1997
- Identification of Immunodominant Regions and Linear B Cell Epitopes of the gE Envelope Protein of Varicella-Zoster VirusVirology, 1995